AA
MLNT

AlphaMark Advisors’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-390
Closed -$1K 524
2019
Q3
$1K Sell
390
-390
-50% -$1K ﹤0.01% 481
2019
Q2
$5K Buy
+780
New +$5K ﹤0.01% 420